OTC · CIK 0000868278
PRPH ProPhase Labs, Inc.
Insider trading from SEC Form 4. Last filing Sep 11, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
4
with a Form 4 at this company
Signals
Open-market buys and sells at ProPhase Labs, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 4 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2025 | Ted William Karkus CEO & CHAIRMAN | AGrant or award warrantsderivative | +500,000 | $0.00 | $0 | 500,000 | Sep 11, 2025 |
| Feb 17, 2025 | Stuart Hollenshead Chief Operating Officer | AGrant or award Option (right to buy)derivative | +500,000 | $0.00 | $0 | 500,000 | Feb 21, 2025 |
| Feb 14, 2025 | Louis Gleckel Md director | AGrant or award Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Feb 18, 2025 |
| Feb 14, 2025 | Warren Hirsch director | AGrant or award Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Feb 18, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Louis Gleckel Mddirector
- Warren Hirschdirector
- Stuart HollensheadChief Operating Officer
- Ted William KarkusCEO & CHAIRMAN
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.